These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35483537)

  • 1. Quantitative Blood Volume Analysis and Hemodynamic Measures of Vascular Compliance in Patients With Worsening Heart Failure.
    Rao VN; Andrews J; Applefeld WN; Gray JM; Molinger J; Felker GM; Miller WL; Patel MR; Hernandez AF; Fudim M
    J Card Fail; 2022 Sep; 28(9):1469-1474. PubMed ID: 35483537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis.
    Beale AL; Nanayakkara S; Segan L; Mariani JA; Maeder MT; van Empel V; Vizi D; Evans S; Lam CSP; Kaye DM
    JACC Heart Fail; 2019 Mar; 7(3):239-249. PubMed ID: 30819380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction.
    Borlaug BA; Nishimura RA; Sorajja P; Lam CS; Redfield MM
    Circ Heart Fail; 2010 Sep; 3(5):588-95. PubMed ID: 20543134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood volume expansion, normovolemia, and clinical outcomes in chronic human heart failure: more is better.
    Miller WL; Strobeck JE; Grill DE; Mullan BP
    Am J Physiol Heart Circ Physiol; 2021 Dec; 321(6):H1074-H1082. PubMed ID: 34676782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure.
    Fujimoto N; Borlaug BA; Lewis GD; Hastings JL; Shafer KM; Bhella PS; Carrick-Ranson G; Levine BD
    Circulation; 2013 Jan; 127(1):55-62. PubMed ID: 23172838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic Responses to Provocative Maneuvers during Right Heart Catheterization.
    Montané B; Tonelli AR; Arunachalam A; Bhattacharyya A; Li M; Wang X; Chaisson NF
    Ann Am Thorac Soc; 2022 Dec; 19(12):1977-1985. PubMed ID: 35802812
    [No Abstract]   [Full Text] [Related]  

  • 7. Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure.
    Borlaug BA; Blair J; Bergmann MW; Bugger H; Burkhoff D; Bruch L; Celermajer DS; Claggett B; Cleland JGF; Cutlip DE; Dauber I; Eicher JC; Gao Q; Gorter TM; Gustafsson F; Hayward C; van der Heyden J; Hasenfuß G; Hummel SL; Kaye DM; Komtebedde J; Massaro JM; Mazurek JA; McKenzie S; Mehta SR; Petrie MC; Post MC; Nair A; Rieth A; Silvestry FE; Solomon SD; Trochu JN; Van Veldhuisen DJ; Westenfeld R; Leon MB; Shah SJ;
    Circulation; 2022 May; 145(21):1592-1604. PubMed ID: 35354306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise oscillatory ventilation in systolic heart failure: an indicator of impaired hemodynamic response to exercise.
    Murphy RM; Shah RV; Malhotra R; Pappagianopoulos PP; Hough SS; Systrom DM; Semigran MJ; Lewis GD
    Circulation; 2011 Sep; 124(13):1442-51. PubMed ID: 21875912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction.
    Wolsk E; Kaye D; Komtebedde J; Shah SJ; Borlaug BA; Burkhoff D; Kitzman DW; Lam CSP; van Veldhuisen DJ; Ponikowski P; Petrie MC; Hassager C; Møller JE; Gustafsson F
    JACC Heart Fail; 2019 Apr; 7(4):321-332. PubMed ID: 30852235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
    Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
    Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of cardiac dysfunction and volume status to central haemodynamics in chronic heart failure.
    Miller WL; Sorimachi H; Grill DE; Fischer K; Borlaug BA
    Eur J Heart Fail; 2021 Jul; 23(7):1097-1105. PubMed ID: 33565251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Anemia on Cardiovascular Hemodynamics, Therapeutic Strategy and Clinical Outcomes in Patients With Heart Failure and Hemodynamic Congestion.
    Tanimura M; Dohi K; Fujimoto N; Moriwaki K; Omori T; Sato Y; Sugiura E; Kumagai N; Nakamori S; Kurita T; Fujii E; Yamada N; Ito M
    Circ J; 2017 Oct; 81(11):1670-1677. PubMed ID: 28626160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous Measurement of Lung Diffusing Capacity and Pulmonary Hemodynamics Reveals Exertional Alveolar-Capillary Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Fermoyle CC; Stewart GM; Borlaug BA; Johnson BD
    J Am Heart Assoc; 2021 Aug; 10(16):e019950. PubMed ID: 34369164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of Pulse Amplitude Changes During the Valsalva Maneuver Measured Using Finger Photoplethysmography to Identify Elevated Pulmonary Capillary Wedge Pressure in Patients With Heart Failure.
    Gilotra NA; Tedford RJ; Wittstein IS; Yenokyan G; Sharma K; Russell SD; Silber HA
    Am J Cardiol; 2017 Sep; 120(6):966-972. PubMed ID: 28754567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of increased venous pressure on kidney function and mortality in cardiovascular patients with preserved ejection fraction.
    Milkas A; Tsioufis K; Koliastasis L; Tsiamis E; Tousoulis D; Bartunek J; Vanderheyden M
    Curr Med Res Opin; 2020 Mar; 36(3):353-359. PubMed ID: 31868029
    [No Abstract]   [Full Text] [Related]  

  • 16. Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure With Preserved Ejection Fraction.
    Baratto C; Caravita S; Soranna D; Faini A; Dewachter C; Zambon A; Perego GB; Bondue A; Senni M; Badano LP; Parati G; Vachiéry JL
    Circ Heart Fail; 2021 May; 14(5):e007555. PubMed ID: 33951935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance and prognostic impact of v wave on pulmonary artery pressure in patients with heart failure: beyond the wedge pressure.
    Iwano H; Yokoyama S; Kamiya K; Nagai T; Tsujinaga S; Sarashina M; Ishizaka S; Chiba Y; Nakabachi M; Nishino H; Murayama M; Okada K; Kaga S; Anzai T
    Heart Vessels; 2020 Aug; 35(8):1079-1086. PubMed ID: 32161994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood volume and brain natriuretic peptide in congestive heart failure: a pilot study.
    James KB; Troughton RW; Feldschuh J; Soltis D; Thomas D; Fouad-Tarazi F
    Am Heart J; 2005 Nov; 150(5):984. PubMed ID: 16290978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure.
    Andersen MJ; Olson TP; Melenovsky V; Kane GC; Borlaug BA
    Circ Heart Fail; 2015 Jan; 8(1):41-8. PubMed ID: 25342738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenic size as an indicator of hemodynamics and prognosis in patients with heart failure.
    Hiraiwa H; Okumura T; Sawamura A; Araki T; Mizutani T; Kazama S; Kimura Y; Shibata N; Oishi H; Kuwayama T; Kondo T; Furusawa K; Morimoto R; Murohara T
    Heart Vessels; 2022 Aug; 37(8):1344-1355. PubMed ID: 35092456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.